Clinical Trials Browser

Phase 3 × HR+/HER2-breast Cancer × apatinib × Clear all

NCT05889871 2023-06-05

A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer

Phase 3 Not yet recruiting

HR+/HER2-breast Cancer